ABVC BioPharma, Inc.ABVC BioPharma, Inc.ABVC BioPharma, Inc.

ABVC BioPharma, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.74 M‬USD
−1.7033USD
‪−10.52 M‬USD
‪152.43 K‬USD
‪10.54 M‬
Beta (1Y)
1.77
Employees (FY)
19
Change (1Y)
−4 −17.39%
Revenue / Employee (1Y)
‪8.02 K‬USD
Net income / Employee (1Y)
‪−553.46 K‬USD

About ABVC BioPharma, Inc.


CEO
Uttam Yashwant Patil
Headquarters
Fremont
Founded
1990
FIGI
BBG000Q844Z2
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ABVC is 0.5300 USD — it has decreased by −1.92% in the past 24 hours. Watch ABVC BioPharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ABVC BioPharma, Inc. stocks are traded under the ticker ABVC.
ABVC stock has fallen by −22.51% compared to the previous week, the month change is a −3.14% fall, over the last year ABVC BioPharma, Inc. has showed a −54.70% decrease.
ABVC reached its all-time high on Jul 20, 2007 with the price of 7,163,325.0000 USD, and its all-time low was 0.4053 USD and was reached on Oct 10, 2024. View more price dynamics on ABVC chart.
See other stocks reaching their highest and lowest prices.
ABVC stock is 9.43% volatile and has beta coefficient of 1.77. Track ABVC BioPharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is ABVC BioPharma, Inc. there?
Today ABVC BioPharma, Inc. has the market capitalization of ‪6.74 M‬, it has increased by 0.14% over the last week.
Yes, you can track ABVC BioPharma, Inc. financials in yearly and quarterly reports right on TradingView.
ABVC BioPharma, Inc. is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
ABVC net income for the last quarter is ‪−1.01 M‬ USD, while the quarter before that showed ‪−3.93 M‬ USD of net income which accounts for 74.25% change. Track more ABVC BioPharma, Inc. financial stats to get the full picture.
No, ABVC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 19.00 employees. See our rating of the largest employees — is ABVC BioPharma, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABVC BioPharma, Inc. EBITDA is ‪−8.51 M‬ USD, and current EBITDA margin is ‪−5.37 K‬%. See more stats in ABVC BioPharma, Inc. financial statements.
Like other stocks, ABVC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABVC BioPharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABVC BioPharma, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABVC BioPharma, Inc. stock shows the sell signal. See more of ABVC BioPharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.